252 related articles for article (PubMed ID: 9563065)
1. Drug exsorption from blood into the gastrointestinal tract.
Arimori K; Nakano M
Pharm Res; 1998 Mar; 15(3):371-6. PubMed ID: 9563065
[TBL] [Abstract][Full Text] [Related]
2. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological role of P-glycoprotein in the intestinal epithelium.
Van Asperen J; Van Tellingen O; Beijnen JH
Pharmacol Res; 1998 Jun; 37(6):429-35. PubMed ID: 9695116
[TBL] [Abstract][Full Text] [Related]
4. Influence of dietary components on the gastrointestinal metabolism and transport of drugs.
Evans AM
Ther Drug Monit; 2000 Feb; 22(1):131-6. PubMed ID: 10688276
[TBL] [Abstract][Full Text] [Related]
5. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro.
Adachi Y; Suzuki H; Sugiyama Y
Pharm Res; 2003 Aug; 20(8):1163-9. PubMed ID: 12948013
[TBL] [Abstract][Full Text] [Related]
7. Modulation of oral bioavailability of anticancer drugs: from mouse to man.
Schellens JH; Malingré MM; Kruijtzer CM; Bardelmeijer HA; van Tellingen O; Schinkel AH; Beijnen JH
Eur J Pharm Sci; 2000 Dec; 12(2):103-10. PubMed ID: 11102737
[TBL] [Abstract][Full Text] [Related]
8. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
Kwon H; Lionberger RA; Yu LX
Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
[TBL] [Abstract][Full Text] [Related]
9. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
Neuhoff S; Ungell AL; Zamora I; Artursson P
Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
Saitoh H; Aungst BJ
Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
[TBL] [Abstract][Full Text] [Related]
11. Modulation of expression/function of intestinal P-glycoprotein under disease states.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
[No Abstract] [Full Text] [Related]
12. Intestinal drug transporters: in vivo function and clinical importance.
Kunta JR; Sinko PJ
Curr Drug Metab; 2004 Feb; 5(1):109-24. PubMed ID: 14965254
[TBL] [Abstract][Full Text] [Related]
13. Targeting intestinal transporters for optimizing oral drug absorption.
Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Drug or Food with Drug Transporters in Intestine and Liver.
Nakanishi T; Tamai I
Curr Drug Metab; 2015; 16(9):753-64. PubMed ID: 26630906
[TBL] [Abstract][Full Text] [Related]
15. Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.
Arimori K; Kuroki N; Hidaka M; Iwakiri T; Yamsaki K; Okumura M; Ono H; Takamura N; Kikuchi M; Nakano M
Pharm Res; 2003 Jun; 20(6):910-7. PubMed ID: 12817897
[TBL] [Abstract][Full Text] [Related]
16. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
17. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
Karlsson J; Kuo SM; Ziemniak J; Artursson P
Br J Pharmacol; 1993 Nov; 110(3):1009-16. PubMed ID: 7905337
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
Fromm MF
Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
[TBL] [Abstract][Full Text] [Related]
19. [Molecular characterization of intestinal absorption of drugs by carrier-mediated transport mechanisms].
Tamai I
Yakugaku Zasshi; 1997 Jul; 117(7):415-34. PubMed ID: 9261213
[TBL] [Abstract][Full Text] [Related]
20. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
Tam D; Tirona RG; Pang KS
Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]